View in EDS

RAD52 inhibition enhances olaparib efficacy in poly (ADP-ribose) polymerase inhibitor-resistant BRCA-deficient ovarian cancer.

Saved in:
Bibliographic Details
Title: RAD52 inhibition enhances olaparib efficacy in poly (ADP-ribose) polymerase inhibitor-resistant BRCA-deficient ovarian cancer.
Authors: Ota, Yukihide1 (AUTHOR), Gupta, Vijayalaxmi1 (AUTHOR), Fashemi, Bisiayo1 (AUTHOR), Akande, Moreniola1 (AUTHOR), Preedia Babu, E.1 (AUTHOR), Sanders, Brooke1 (AUTHOR), Kuroki, Lindsay1 (AUTHOR), McCourt, Carolyn1 (AUTHOR), Hagemann, Andrea1 (AUTHOR), Hagemann, Ian1 (AUTHOR), Thaker, Premal1 (AUTHOR), Mutch, David1 (AUTHOR), Powell, Matthew1 (AUTHOR), Verma, Priyanka1 (AUTHOR), Krais, John1 (AUTHOR), Bitler, Benjamin2 (AUTHOR), Fuh, Katherine3 (AUTHOR), Mullen, Mary1 (AUTHOR), Khabele, Dineo1 (AUTHOR)
Source: Gynecologic Oncology. 2025 Supplement 1, Vol. 200, p44-45. 2p.
Database: Academic Search Ultimate
Description
ISSN:00908258
DOI:10.1016/j.ygyno.2025.04.014